Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 211-220 of 409 for breast cancer

Edit search filters
  1. A Pilot Study Utilizing Proteomic And Genomic Profiling For Patients With Metastatic Breast Cancer

    Scottsdale/Phoenix, AZ

  2. Individualizing Approaches To Surveillance Mammography In Older Breast Cancer Survivors - The I-MAMMO Study

    Rochester, MN

  3. A Study Of Pembrolizumab Alone As Therapy For Metastatic Triple-Negative Breast Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  4. Advancing Survivorship Support Through Virtual Health Equity Resources For Breast Cancer Responsive Education

    Jacksonville, FL

  5. Docetaxel And Cyclophosphamide Compared To Anthracycline-Based Chemotherapy In Treating Women With HER2-Negative Breast Cancer

    Rochester, MN

  6. Phase 1 Study Of CLR 125 In Triple Negative Breast Cancer

    Jacksonville, FL, Rochester, MN

  7. A Study Of Abemaciclib (LY2835219) In Women With HR+, HER2+ Locally Advanced Or Metastatic Breast Cancer

    Rochester, MN

  8. A Study Of Niraparib Combined With Pembrolizumab (MK-3475) In Patients Who Have Triple-Negative Breast Cancer Or Ovarian Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  9. Anastrozole And Letrozole After Surgery For The Treatment Of Stage I-III Breast Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  10. Taselisib And Enzalutamide In Treating Patients With Androgen Receptor Positive Triple-Negative Metastatic Breast Cancer

    Rochester, MN

.

Mayo Clinic Footer